rs185181365
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_144670.6(A2ML1):c.1237G>A(p.Val413Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000897 in 1,613,072 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V413D) has been classified as Uncertain significance.
Frequency
Consequence
NM_144670.6 missense
Scores
Clinical Significance
Conservation
Publications
- Noonan syndromeInheritance: AD Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000486 AC: 74AN: 152130Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000391 AC: 97AN: 247936 AF XY: 0.000372 show subpopulations
GnomAD4 exome AF: 0.000940 AC: 1373AN: 1460824Hom.: 1 Cov.: 31 AF XY: 0.000864 AC XY: 628AN XY: 726634 show subpopulations
GnomAD4 genome AF: 0.000486 AC: 74AN: 152248Hom.: 0 Cov.: 31 AF XY: 0.000430 AC XY: 32AN XY: 74446 show subpopulations
ClinVar
Submissions by phenotype
not provided Benign:3
A2ML1: BP4 -
- -
- -
not specified Benign:1
Variant summary: A2ML1 c.1237G>A (p.Val413Ile) results in a conservative amino acid change located in the Macroglobulin domain MG4 (IPR040839) of the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00039 in 247936 control chromosomes (gnomAD). The observed variant frequency is approximately 98 fold of the estimated maximal expected allele frequency for a pathogenic variant in A2ML1 causing Noonan Syndrome phenotype (4e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.1237G>A in individuals affected with Noonan Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One ClinVar submitter (evaluation after 2014) cites the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign. -
A2ML1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at